Corrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]

Simple item page
dc.contributor.authorEl Hindi T.
dc.contributor.authorAnugulruengkitt S.
dc.contributor.authorLapphra K.
dc.contributor.authorLimkittikul K.
dc.contributor.authorTangsathapornpong A.
dc.contributor.authorGalindo C.M.
dc.contributor.authorHellwig M.
dc.contributor.authorRoubinis N.
dc.contributor.authorSchuring R.
dc.contributor.authorBiswal S.
dc.contributor.authorFolschweiller N.
dc.contributor.correspondenceEl Hindi T.
dc.contributor.otherMahidol University
dc.date.accessioned2025-10-17T18:12:03Z
dc.date.available2025-10-17T18:12:03Z
dc.date.issued2025-01-01
dc.identifier.citationVaccine (2025)
dc.identifier.doi10.1016/j.vaccine.2025.127785
dc.identifier.eissn18732518
dc.identifier.issn0264410X
dc.identifier.scopus2-s2.0-105018050839
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/112626
dc.rights.holderSCOPUS
dc.subjectBiochemistry, Genetics and Molecular Biology
dc.subjectMedicine
dc.subjectImmunology and Microbiology
dc.subjectVeterinary
dc.titleCorrigendum to “Immunogenicity and safety of the live-attenuated tetravalent dengue vaccine (TAK-003) co-administered with recombinant 9-valent human papillomavirus vaccine” [Vaccine 62 (2025) 127558]
dc.typeErratum
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=105018050839&origin=inward
oaire.citation.titleVaccine
oairecerif.author.affiliationSiriraj Hospital
oairecerif.author.affiliationFaculty of Tropical Medicine, Mahidol University
oairecerif.author.affiliationFaculty of Medicine, Chulalongkorn University
oairecerif.author.affiliationFaculty of Medicine, Thammasat University
oairecerif.author.affiliationTakeda Pharma AG

Files

Collections

Scopus 2025